AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/162

Authors: GIRMA JP FRESSINAUD E HOULLIER A LAURIAN Y AMIRAL J MEYER D
Citation: Jp. Girma et al., ASSAY OF FACTOR-VIII ANTIGEN (VIII-CAG) IN 294 HEMOPHILIA-A PATIENTS BY A NEW COMMERCIAL ELISA USING MONOCLONAL-ANTIBODIES, Haemophilia, 4(2), 1998, pp. 98-103

Authors: ESCOFFREBARBE M OGER E LEROYER C GRIMAUX M LEMOIGNE E NONENT M BRESSOLLETTE L ABGRALL JF SORIA C AMIRAL J ILL P CLAVIER J MOTTIER D
Citation: M. Escoffrebarbe et al., EVALUATION OF A NEW RAPID D-DIMER ASSAY FOR CLINICALLY SUSPECTED DEEPVENOUS THROMBOSIS (LIATEST D-DIMER), AJCP. American journal of clinical pathology, 109(6), 1998, pp. 748-753

Authors: OGER E LEROYER C BRESSOLLETTE L NONENT M LEMOIGNE E BIZAIS Y AMIRAL J GRIMAUX M CLAVIER J ILL P ABGRALL JF MOTTIER D
Citation: E. Oger et al., EVALUATION OF A NEW, RAPID, AND QUANTITATIVE D-DIMER TEST IN PATIENTSWITH SUSPECTED PULMONARY-EMBOLISM, American journal of respiratory and critical care medicine, 158(1), 1998, pp. 65-70

Authors: BLANN AD LYDAKIS C LANDRAY MJ SINGH S WATSON RDS ZARIFIS J AMIRAL J BEEVERS D LIP GYH
Citation: Ad. Blann et al., ENDOTHELIAL AND PLATELET ACTIVATION FOLLOWING STREPTOKINASE FOR ACUTEMYOCARDIAL-INFARCTION, Journal of vascular research, 35, 1998, pp. 109-109

Authors: RESPLANDY F DUPUY R SEIGNEUR M MERCIE P CONSTANS J FACH J LONGYBOURSIER M PELLEGRIN JL AMIRAL J BOISSEAU M CONRI C
Citation: F. Resplandy et al., ANTIENDOTHELIAL CELL ANTIBODIES AND SYSTEMIC LUPUS-ERYTHEMATOSUS DISEASE-ACTIVITY, Journal of vascular research, 35, 1998, pp. 113-113

Authors: BLANN AD DEVINE C AMIRAL J MCCOLLUM CN
Citation: Ad. Blann et al., SOLUBLE ADHESION MOLECULES, ENDOTHELIAL MARKERS AND ATHEROSCLEROSIS RISK-FACTORS IN ABDOMINAL AORTIC-ANEURYSM - A COMPARISON WITH CLAUDICANTS AND HEALTHY CONTROLS, Blood coagulation & fibrinolysis, 9(6), 1998, pp. 479-484

Authors: KAISER B GLUSA E HOPPENSTEADT DA BREDDIN HK AMIRAL J FAREED J
Citation: B. Kaiser et al., A SUPERSULFATED LOW-MOLECULAR-WEIGHT HEPARIN (IK-SSH) INCREASES PLASMA-LEVELS OF FREE AND TOTAL TISSUE FACTOR PATHWAY INHIBITOR AFTER INTRAVENOUS AND SUBCUTANEOUS ADMINISTRATION IN HUMANS, Blood coagulation & fibrinolysis, 9(6), 1998, pp. 517-523

Authors: ESCHWEGE V PEYNAUDDEBAYLE E WOLF M AMIRAL J VISSAC AM BRIDEY F DREYFUS M BOYERNEUMANN C MEYER D
Citation: V. Eschwege et al., PREVALENCE OF ANTIPHOSPHOLIPID-RELATED ANTIBODIES IN UNSELECTED PATIENTS WITH HISTORY OF VENOUS THROMBOSIS, Blood coagulation & fibrinolysis, 9(5), 1998, pp. 429-434

Authors: RAVANAT C WIESEL ML SCHUHLER S DAMBACH J AMIRAL J CAZENAVE JP
Citation: C. Ravanat et al., ONE-STEP ASSAY FOR THE DETERMINATION OF FREE PROTEIN-S ANTIGEN IN PLASMA USING REAL-TIME BIOSPECIFIC INTERACTION ANALYSIS, Blood coagulation & fibrinolysis, 9(4), 1998, pp. 333-341

Authors: OGER E LEROYER C MERCIER B VANDREDEN P BRESSOLLETTE L DESAINTMARTIN L LEMOIGNE E BLOUCH MT THUILLIER N AMIRAL J FEREC C ABGRALL JF MOTTIER D
Citation: E. Oger et al., ASSESSMENT OF ACTIVATED PROTEIN-C RESISTANCE USING A NEW AND RAPID VENOM-BASED TEST - STA STACLOT APC-R, Blood coagulation & fibrinolysis, 9(4), 1998, pp. 355-359

Authors: FALKON L GARI M BARBANOJ M AMIRAL J FONTCUBERTA J
Citation: L. Falkon et al., TISSUE FACTOR PATHWAY INHIBITOR AND ANTI-FXA KINETIC PROFILES OF A NEW LOW-MOLECULAR-MASS HEPARIN, BEMIPARIN, AT THERAPEUTIC SUBCUTANEOUS DOSES, Blood coagulation & fibrinolysis, 9(2), 1998, pp. 137-141

Authors: AMIRAL J MARFAINGKOKA A PONCZ M MEYER D
Citation: J. Amiral et al., THE BIOLOGICAL BASIS OF IMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA, Platelets, 9(2), 1998, pp. 77-91

Authors: FAREED J HOPPENSTEADT D JESKE W AMIRAL J WALENGA J
Citation: J. Fareed et al., NONHEPARIN GLYCOSAMINOGLYCANS INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, The FASEB journal, 12(5), 1998, pp. 4157-4157

Authors: BOZOVICH G GURFINKEL E MAUTNER B BLANCO P AMIRAL J FAREED J
Citation: G. Bozovich et al., FREE TISSUE FACTOR PATHWAY INHIBITOR IS ELEVATED IN PATIENTS WITH ACUTE NON-Q-WAVE CORONARY SYNDROMES, The FASEB journal, 12(5), 1998, pp. 4178-4178

Authors: HOPPENSTEADT D FAREED J AMIRAL J JESKE W WALENGA J LEWIS B WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CARDIOVASCULAR SYNDROMES, The FASEB journal, 12(5), 1998, pp. 5532-5532

Authors: HOPPENSTEADT D FAREED J AMIRAL J JESKE W WALENGA JM LEWIS B WELZEL D
Citation: D. Hoppensteadt et al., TISSUE FACTOR PATHWAY INHIBITOR RELEASE IS SPECIFIC FOR HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS - IMPLICATIONS IN THE MANAGEMENT OF CORONARY SYNDROMES, Journal of the American College of Cardiology, 31(2), 1998, pp. 53-53

Authors: SAMAMA MS GOUINTHIBAULT I TROSSAERT M VANDREDEN P COMBOT C AMIRAL J HORELLOU MH CONARD J
Citation: Ms. Samama et al., LOW-LEVELS OF PROTEIN-S ACTIVITY IN FACTOR-V DEPLETED PLASMA USED IN APC RESISTANCE TEST, Thrombosis and haemostasis, 80(4), 1998, pp. 715-716

Authors: BOFFA MC VALSECCHI L FAUSTO A GOZIN D DANGELO SV SAFA O CASTIGLIONI MT AMIRAL J DANGELO A
Citation: Mc. Boffa et al., PREDICTIVE VALUE OF PLASMA THROMBOMODULIN IN PREECLAMPSIA AND GESTATIONAL HYPERTENSION, Thrombosis and haemostasis, 79(6), 1998, pp. 1092-1095

Authors: DEMOERLOOSE P MERMILLOD N AMIRAL J REBER G
Citation: P. Demoerloose et al., THROMBOMODULIN LEVELS DURING NORMAL-PREGNANCY, AT DELIVERY AND IN THEPOSTPARTUM - COMPARISON WITH TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1, Thrombosis and haemostasis, 79(3), 1998, pp. 554-556

Authors: GRETEN J KREIS I LILIENSIEK B ALLENBERG J AMIRAL J ZIEGLER R NAWROTH PP
Citation: J. Greten et al., LOCALIZATION OF PROTEIN-Z IN VASCULAR-LESIONS OF PATIENTS WITH ATHEROSCLEROSIS, VASA, 27(3), 1998, pp. 144-148

Authors: HOFMANN MA KOHL B ZUMBACH MS BORCEA V BIERHAUS A HENKELS M AMIRAL J SCHMIDT AM FIEHN W ZIEGLER R WAHL P NAWROTH PP
Citation: Ma. Hofmann et al., HYPERHOMOCYST(E)INEMIA AND ENDOTHELIAL DYSFUNCTION IN IDDM, Diabetes care, 21(5), 1998, pp. 841-848

Authors: HOFMANN MA KOHL B ZUMBACH MS BORCEA V BIERHAUS A HENKELS M AMIRAL J FIEHN W ZIEGLER R WAHL P NAWROTH PP
Citation: Ma. Hofmann et al., HYPERHOMOCYST(E)INEMIA AND ENDOTHELIAL DYSFUNCTION IN IDDM (VOL 20, PG 1880, 1997), Diabetes care, 21(4), 1998, pp. 678-678

Authors: REBER G AMIRAL J DEMOERLOOSE P
Citation: G. Reber et al., MODIFIED ANTITHROMBIN-III LEVELS DURING NORMAL-PREGNANCY AND RELATIONSHIP WITH PROTHROMBIN FRAGMENT F1-ANTITHROMBIN COMPLEXES(2 AND THROMBIN), Thrombosis research, 91(1), 1998, pp. 45-47

Authors: CONSTANS J GUERIN V COUCHOURON A SEIGNEUR M RYMAN A BLANN AD AMIRAL J AMARA A PEUCHANT E MOREAU JF PELLEGRIN I PELLEGRIN JL FLEURY H LENG B CONRI C
Citation: J. Constans et al., AUTOANTIBODIES DIRECTED AGAINST PHOSPHOLIPIDS OR HUMAN BETA(2)-GLYCOPROTEIN-I IN HIV-SEROPOSITIVE PATIENTS - RELATIONSHIP WITH ENDOTHELIAL ACTIVATION AND ANTIMALONIC DIALDEHYDE ANTIBODIES, European journal of clinical investigation, 28(2), 1998, pp. 115-122

Authors: FAREED J HOPPENSTEADT DA JESKE W AMIRAL J WALENGA JM
Citation: J. Fareed et al., NON-HEPARIN GLYCOSAMINOGLYCANS-INDUCED GENERATION OF ANTIPLATELET FACTOR-4 HEPARIN ANTIBODIES - IMPLICATIONS IN THE MANAGEMENT OF HIT SYNDROME, Clinical chemistry, 44, 1998, pp. 212-212
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>